Identification and Functional Evaluation of a Novel <i>TBX4</i> Mutation Underlies Small Patella Syndrome

Ping Li,Wenli Lan,Jiaying Li,Yanping Zhang,Qiuhong Xiong,Jinpei Ye,Changxin Wu,Han Xiao
DOI: https://doi.org/10.3390/ijms23042075
IF: 5.6
2022-01-01
International Journal of Molecular Sciences
Abstract:Small patella syndrome (SPS) is a rare autosomal dominant disorder caused by mutations in TBX4 gene which encodes a transcription factor of FGF10. However, how TBX4 mutations result in SPS is poorly understood. Here, a novel TBX4 mutation c.1241C>T (p.P414L) was identified in a SPS family and series of studies were performed to evaluate the influences of TBX4 mutations (including c.1241C>T and two known mutations c.256G>C and c.743G>T). Results showed that mesenchymal stem cells (MSCs) with stable overexpression of either TBX4 wild-type (TBX4(wt)) or mutants (TBX4(mt)) were successfully generated. Immunofluorescence study revealed that both the overexpressed TBX4 wild-type and mutants were evenly expressed in the nucleus suggesting that these mutations do not alter the translocation of TBX4 into the nucleus. Interestingly, MSCs overexpression of TBX4(mt) exhibited reduced differentiation activities and decreased FGF10 expression. Chromatin immunoprecipitation (ChIP) study demonstrated that TBX4 mutants still could bind to the promoter of FGF10. However, dual luciferase reporter assay clarified that the binding efficiencies of TBX4 mutants to FGF10 promoter were reduced. Taken together, MSCs were firstly used to study the function of TBX4 mutations in this study and the results indicate that the reduced binding efficiencies of TBX4 mutants (TBX4(mt)) to the promoter of FGF10 result in the abnormal biological processes which provide important information for the pathogenesis of SPS.
What problem does this paper attempt to address?